Page last updated: 2024-11-05

thiabendazole and Hematologic Malignancies

thiabendazole has been researched along with Hematologic Malignancies in 1 studies

Tresaderm: dermatologic soln containing dexamethasone, thiabendazole & neomycin sulfate

Research Excerpts

ExcerptRelevanceReference
"A total of 21 patients with hematologic malignancies were given thiabendazole for treatment of strongyloidiasis."9.09Thiabendazole for the treatment of strongyloidiasis in patients with hematologic malignancies. ( Almeida, L; Castro, MB; Ferreira, SB; Nucci, M; Portugal, R; Pulcheri, W; Schaffel, R; Spector, N, 2000)
"A total of 21 patients with hematologic malignancies were given thiabendazole for treatment of strongyloidiasis."5.09Thiabendazole for the treatment of strongyloidiasis in patients with hematologic malignancies. ( Almeida, L; Castro, MB; Ferreira, SB; Nucci, M; Portugal, R; Pulcheri, W; Schaffel, R; Spector, N, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schaffel, R1
Nucci, M1
Portugal, R1
Castro, MB1
Ferreira, SB1
Almeida, L1
Spector, N1
Pulcheri, W1

Trials

1 trial available for thiabendazole and Hematologic Malignancies

ArticleYear
Thiabendazole for the treatment of strongyloidiasis in patients with hematologic malignancies.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000, Volume: 31, Issue:3

    Topics: Adolescent; Adult; Aged; Antinematodal Agents; Child; Dizziness; Female; Follow-Up Studies; Hematolo

2000